Clinical trial
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
NCT00002506 · Hoag Memorial Hospital Presbyterian, Other · Completed
Key facts
| NCT number | NCT00002506 |
|---|---|
| Title | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer |
| Official title | ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS |
| Lead sponsor | Hoag Memorial Hospital Presbyterian, Other |
| Collaborators | Cancer Biotherapy Research Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Esophageal Cancer, Head and Neck Cancer, Lung Cancer, Non-melanomatous Skin Cancer, Penile Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, isotretinoin |
| Start date | Aug 1, 1992 |
| Primary completion | Jan 1, 1996 |
| Completion | Feb 1, 1999 |
| First posted | Jul 26, 2004 |
| Last update posted | May 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: